NM_001386974.1:c.391G>T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001386974.1(KCNN1):​c.391G>T​(p.Val131Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000987 in 1,418,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000099 ( 0 hom. )

Consequence

KCNN1
NM_001386974.1 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.58

Publications

0 publications found
Variant links:
Genes affected
KCNN1 (HGNC:6290): (potassium calcium-activated channel subfamily N member 1) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. The protein encoded by this gene is activated before membrane hyperpolarization and is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. The encoded protein is an integral membrane protein that forms a voltage-independent calcium-activated channel with three other calmodulin-binding subunits. This gene is a member of the KCNN family of potassium channel genes. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23555109).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNN1NM_001386974.1 linkc.391G>T p.Val131Leu missense_variant Exon 2 of 10 ENST00000684775.1 NP_001373903.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNN1ENST00000684775.1 linkc.391G>T p.Val131Leu missense_variant Exon 2 of 10 NM_001386974.1 ENSP00000507021.1 Q92952-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000464
AC:
1
AN:
215534
AF XY:
0.00000864
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000987
AC:
14
AN:
1418836
Hom.:
0
Cov.:
31
AF XY:
0.00000857
AC XY:
6
AN XY:
700392
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32314
American (AMR)
AF:
0.00
AC:
0
AN:
40556
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23396
East Asian (EAS)
AF:
0.0000767
AC:
3
AN:
39138
South Asian (SAS)
AF:
0.0000125
AC:
1
AN:
80310
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51304
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5574
European-Non Finnish (NFE)
AF:
0.00000276
AC:
3
AN:
1087800
Other (OTH)
AF:
0.000120
AC:
7
AN:
58444
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 20, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.391G>T (p.V131L) alteration is located in exon 3 (coding exon 1) of the KCNN1 gene. This alteration results from a G to T substitution at nucleotide position 391, causing the valine (V) at amino acid position 131 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.030
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
22
DANN
Benign
0.92
DEOGEN2
Benign
0.26
T;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.36
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.82
T;T
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.24
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L;.
PhyloP100
2.6
PrimateAI
Benign
0.48
T
REVEL
Benign
0.049
Sift4G
Benign
0.30
T;T
Polyphen
0.0050
B;.
Vest4
0.15
MutPred
0.59
Gain of helix (P = 0.0199);Gain of helix (P = 0.0199);
MVP
0.15
MPC
0.53
ClinPred
0.69
D
GERP RS
3.2
Varity_R
0.090
gMVP
0.76
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1456266392; hg19: chr19-18085088; API